CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Oppenheimer Downgrades Capricor Therapeutics to Perform From Outperform, Price Target is $54

Negative
AI Analysis

Summary

Oppenheimer downgraded Capricor Therapeutics from Outperform to Perform with a price target of $54.

Importance:3/10
Sentiment:
-0.60
analyst_downgraderating_changeprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 30, 2026 2:15 PM

Read Original